Home
Religare, two other Indian companies vying for London stockbrokers
Europe News.Net
Saturday 17th May, 2008 (IANS)
Three Indian companies, including Religare, are bidding to acquire city stockbrokers Arden Partners, the Financial Times reported.
Arden, which Friday ended talks with the larger Cenkos Securities, said it has received preliminary approaches from other parties, "which may nor may not lead to an offer being made for the company".
The newspaper identified the bidders as New Delhi-based Religare Enterprises - controlled by Ranbaxy director Malvinder Singh and his brother Shivinder, Mumbai-based broker JM Financial and an Indian investment bank.
Religare hit the headlines in April when it acquired London's oldest city firm, 205-year-old Hichens Harrison, for 55.5 million pounds (over $100 million).
Meanwhile, Cenkos Securities chief executive Andy Stewart said takeover talks collapsed after Arden non-executive directors demanded a higher price than the estimated 30 million pounds first agreed.
"I thought we had a deal and we had shaken hands on it," the Daily Telegraph quoted him as saying Saturday.
 Email this story to a friend
Have your say on this story
|
 |
 |
- And now, Indian etiquette classes in London
London, July 23 (IANS) Kissing Indian women goodbye is out for young British businessmen and professionals flying out to India to explore new job opportunities. [read story]
- Somdev Devvarman ousted from Lexington Challenger doubles
Lexington (Kentucky), July 23 (IANS) India's Somdev Devvarman and his American partner Rylan Rizza went down fighting to Dominican Republic's Victor Estrella and Mexican Santiago Gonzalez in the opening round of the $50,000 ATP Challenger here. [read story]
- Vote over, Geneva welcomes Kamal Nath
Geneva, July 23 (IANS) Commerce and Industry Minister Kamal Nath's arrival here early Wednesday could galvanise efforts to lay down fair rules of world trade, diplomats said. [read story]
- Can natural sugars help create stem cell therapies?
London, July 23 (IANS) Scientists are examining whether the body's natural sugars can be utilised for creating stem cell treatments for heart disease and to repair nerve damage. [read story]
- Family history 'cannot predict breast cancer risk in women'
Washington, July 24 : Refuting claims of previous studies, researchers from Leiden University Medical Centre in the Netherlands have revealed that family history cannot be taken as a strong predictor of breast cancer risk in women. [read story]
|
|
 |
 |
|
|
